what is gip/glp-1 New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight Indications for GLP-1/GIP RA Summary

6 While many of these agents, such as RAAS blockers, effectively attenuate adverse general cardiac remodeling and improve survival by targeting specific signaling pathways, significant gaps remain in addressing key disease-driving mechanisms, such as chronic inflammation, fibrosis, and metabolic dysregulation

When to Discuss GLP-1 Eligibility With Your Provider If your BMI exceeds 27 with weight-related comorbidities or reaches 30 regardless of comorbidities, GLP-1 may warrant discussion with your primary care or weight management provider

Medical nutritional therapy in pregnant women with pregestational diabetes mellitus

The accumulation of iron and lipid peroxidation primarily initiates oxidative membrane damage during ferroptosis

Methyl B12 with L-MethylfolateEach serving contains a blend of bioavailable folate and vitamin B12 to support healthy methylation, homocysteine regulation, and energy production in a tasty, well-absorbed lozenge

Contraindicated in patients with active malignancy, uncontrolled diabetes, or certain medical conditions